NL192780C - Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof. - Google Patents

Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof. Download PDF

Info

Publication number
NL192780C
NL192780C NL8500323A NL8500323A NL192780C NL 192780 C NL192780 C NL 192780C NL 8500323 A NL8500323 A NL 8500323A NL 8500323 A NL8500323 A NL 8500323A NL 192780 C NL192780 C NL 192780C
Authority
NL
Netherlands
Prior art keywords
map
polymer
water
swellable
cross
Prior art date
Application number
NL8500323A
Other languages
English (en)
Dutch (nl)
Other versions
NL8500323A (nl
NL192780B (nl
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NL8500323A publication Critical patent/NL8500323A/nl
Publication of NL192780B publication Critical patent/NL192780B/xx
Application granted granted Critical
Publication of NL192780C publication Critical patent/NL192780C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL8500323A 1984-02-08 1985-02-06 Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof. NL192780C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8403360 1984-02-08
GB848403360A GB8403360D0 (en) 1984-02-08 1984-02-08 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NL8500323A NL8500323A (nl) 1985-09-02
NL192780B NL192780B (nl) 1997-10-01
NL192780C true NL192780C (nl) 1998-02-03

Family

ID=10556300

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8500323A NL192780C (nl) 1984-02-08 1985-02-06 Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof.

Country Status (32)

Country Link
US (1) US4632828A (ko)
JP (1) JPS60181017A (ko)
KR (1) KR930009897B1 (ko)
AT (1) AT388869B (ko)
AU (1) AU577351B2 (ko)
BE (1) BE901664A (ko)
BG (1) BG60524B2 (ko)
CA (1) CA1240928A (ko)
CH (1) CH664693A5 (ko)
CZ (1) CZ277728B6 (ko)
DE (1) DE3503679A1 (ko)
DK (1) DK164149C (ko)
ES (3) ES8607984A1 (ko)
FI (1) FI84230C (ko)
FR (1) FR2559065B1 (ko)
GB (2) GB8403360D0 (ko)
GR (1) GR850312B (ko)
HK (1) HK94290A (ko)
HU (1) HU194050B (ko)
IE (1) IE58230B1 (ko)
IL (1) IL74241A (ko)
IT (1) IT1209615B (ko)
NL (1) NL192780C (ko)
NO (1) NO170568C (ko)
NZ (1) NZ211058A (ko)
PT (1) PT79933B (ko)
SE (2) SE8500553L (ko)
SG (1) SG80390G (ko)
SK (1) SK278084B6 (ko)
SU (1) SU1605926A3 (ko)
UA (1) UA6028A1 (ko)
ZA (1) ZA85943B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
GB8806367D0 (en) * 1988-03-17 1988-04-13 Erba Carlo Spa Siloxane matrices with internal non-uniform drug distribution
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
AUPS244002A0 (en) * 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
JP2005094910A (ja) * 2003-09-17 2005-04-07 Aruze Corp モータ停止制御装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
AU454482B2 (en) * 1970-11-05 1974-10-15 Alza Corporation Drug-delivery system
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
GB2067900B (en) * 1980-01-25 1983-06-22 Ddsa Pharmaceuticals Ltd Medicinal tablets
DE3006635A1 (de) * 1980-02-22 1981-08-27 Basf Ag, 6700 Ludwigshafen Verwendung von mikronisiertem vernetztem, unloeslichem polyvinylpyrrolidon zur stabilisierung von suspensionen
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
DE3125178A1 (de) * 1981-06-26 1983-01-13 Gödecke AG, 1000 Berlin Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3205399A1 (de) * 1982-02-16 1983-08-25 Bayer Ag, 5090 Leverkusen Feste, schnellfreisetzende arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
EP0084190A3 (en) * 1981-12-08 1984-11-28 Fisons Plc Medicinal composition, package and method of making the composition
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss

Also Published As

Publication number Publication date
KR930009897B1 (ko) 1993-10-13
FR2559065B1 (fr) 1988-09-09
NO170568C (no) 1992-11-04
FI850455L (fi) 1985-08-09
DK57085A (da) 1985-08-09
SE462547B (sv) 1990-07-16
FR2559065A1 (fr) 1985-08-09
PT79933A (en) 1985-03-01
SE8500553D0 (sv) 1985-02-06
GB2153677B (en) 1988-04-13
JPH0415769B2 (ko) 1992-03-19
ZA85943B (en) 1985-10-30
FI850455A0 (fi) 1985-02-04
NO850477L (no) 1985-08-09
AU3848885A (en) 1985-08-15
AU577351B2 (en) 1988-09-22
GB8403360D0 (en) 1984-03-14
GR850312B (ko) 1985-06-05
DK57085D0 (da) 1985-02-07
IE850261L (en) 1985-08-08
HUT37890A (en) 1986-03-28
PT79933B (en) 1987-02-02
KR850005858A (ko) 1985-09-26
SG80390G (en) 1990-11-23
UA6028A1 (uk) 1994-12-29
ES550613A0 (es) 1987-02-16
IT8519385A0 (it) 1985-02-05
DE3503679C2 (ko) 1992-05-07
SE8500553L (sv) 1985-08-09
NL8500323A (nl) 1985-09-02
IL74241A0 (en) 1985-05-31
NZ211058A (en) 1988-09-29
SU1605926A3 (ru) 1990-11-07
IE58230B1 (en) 1993-08-11
GB8503033D0 (en) 1985-03-06
IT1209615B (it) 1989-08-30
CS78485A3 (en) 1992-11-18
GB2153677A (en) 1985-08-29
ES8703277A1 (es) 1987-02-16
ES8703278A1 (es) 1987-02-16
ES8607984A1 (es) 1986-06-01
DE3503679A1 (de) 1985-08-08
HK94290A (en) 1990-11-23
NO170568B (no) 1992-07-27
CH664693A5 (de) 1988-03-31
NL192780B (nl) 1997-10-01
ES539874A0 (es) 1986-06-01
CZ277728B6 (en) 1993-04-14
BE901664A (fr) 1985-08-06
DK164149C (da) 1992-10-12
US4632828A (en) 1986-12-30
ATA31685A (de) 1989-02-15
FI84230C (fi) 1991-11-11
FI84230B (fi) 1991-07-31
IL74241A (en) 1988-12-30
ES550614A0 (es) 1987-02-16
CA1240928A (en) 1988-08-23
HU194050B (en) 1988-01-28
AT388869B (de) 1989-09-11
DK164149B (da) 1992-05-18
BG60524B2 (bg) 1995-07-28
JPS60181017A (ja) 1985-09-14
SK278084B6 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
US4639370A (en) Pharmaceutical composition
NL192780C (nl) Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof.
US5340591A (en) Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
JP2916152B2 (ja) 薬物放出速度調節型製剤
US8337897B2 (en) Immediate release pharmaceutical granule compositions and a continuous process for making them
EP1806129A1 (en) Composition containing fine particles and process for producing the same
Prajapati et al. Studies to Enhance Dissolution Properties of Carbamazepine.
CN102655856A (zh) 纳米粒状奥美沙坦酯组合物、其制备方法及含有它们的药物组合物
WO2007086689A1 (en) A solid dispersion comprising ubidecarenone, a process for preparing the same and a pharmaceutical composition comprising the same
JP2020517578A (ja) 脂質を製粉工程の潤滑剤として用いる活性物質のナノ粒子の製造方法
CN105616369A (zh) 溶出增强型非诺贝特片的制备方法
TW201028168A (en) Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
Dalai et al. Techniques and Carriers used in Solubility Enhancement of Drugs: An Extensive Review
WO2024153733A1 (en) Crystalline nanoparticles comprising enzalutamide
WO2021216022A1 (en) Gel formulation comprising etodolac nanosuspension
PL66157B1 (ko)
DADE et al. FORMULATION OF CELECOXIB IN TO IMMEDIATE RELEASE TABLETS
Pillai Development and Characterization of Solid Dosage form Incorporating Camptothecin Analog Nanoparticles
WO2002072064A2 (en) Granular composition comprising an active compound and a cellulose ether and the use thereof

Legal Events

Date Code Title Description
BV The patent application has lapsed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: ERBAMONT INDUSTRIALE S.R.L.

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: ERBA S.R.L. FARMITALIA CARLO -

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
SNR Assignments of patents or rights arising from examined patent applications

Owner name: PHARMACIA ITALIA S.P.A.

Owner name: PHARMACIA S.P.A.

TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: PHARMACIA & UPJOHN S.P.A.

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20050206